Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Minimally Invasive Ultrasound-Guided Acupotomy in Knee Osteoarthritis Treatment
Published on: April 26, 2024
Using viscosupplementation to treat knee osteoarthritis
1Duke Sports Medicine Center, Durham, NC. tracy.ray@duke.edu.
Viscosupplementation, an injection therapy for osteoarthritis (OA) pain, offers longer relief than NSAIDs and corticosteroids. It is a safe and effective option, particularly in earlier OA stages, as part of comprehensive pain management.
Area of Science:
- Orthopedics
- Sports Medicine
- Rheumatology
Background:
- Osteoarthritis (OA) is a prevalent and disabling condition.
- Conservative treatments and pharmacologic agents like acetaminophen and NSAIDs are common but carry risks with long-term use.
- Physicians need effective, safe alternatives for OA pain management.
Purpose of the Study:
- To provide an overview of viscosupplementation for treating osteoarthritis pain.
- To review the evidence supporting viscosupplementation as a treatment option.
- To discuss its role within a multimodal approach to OA management.
Main Methods:
- Review of existing literature on viscosupplementation for OA.
- Analysis of safety profiles and efficacy of intra-articular hyaluronic acid/hylan injections.
- Comparison of viscosupplementation with other OA treatments.
Main Results:
- Viscosupplementation demonstrates a good safety profile for knee OA pain.
- Injections provide pain relief for up to 26 weeks, exceeding the duration of NSAIDs and corticosteroid injections.
- Treatment may be more beneficial in earlier stages of OA and is effective in multimodal therapy.
Conclusions:
- Viscosupplementation is a safe and effective treatment for osteoarthritis pain, particularly knee OA.
- It offers sustained pain relief and can be a valuable component of comprehensive OA management.
- Its efficacy may be enhanced when initiated in earlier disease stages or combined with other therapies.
More Related Videos
14:49Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration
Published on: September 29, 2018
07:24Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus
Published on: January 23, 2018